In this sense, we propose the use of this new peptide ligand to ECP in the mucus as a screening test of EoE that could complement the first endoscopy examination data to confirm diagnostic hypotheses and follow-up tool for EoE patients. Here, RNASE3 is linked to eosinophilic esophagitis.